OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Kahl on Efficacy of Targeted Agents in Relapsed/Refractory Indolent Lymphomas

April 15th 2020

Brad Kahl, MD, discusses the efficacy of targeted agents across indolent lymphomas.

Dr. Goodman on the Need for Molecular Subtyping in T-Cell Lymphomas

April 15th 2020

Aaron Goodman, MD, discusses the need for molecular subtyping in T-cell lymphomas.

Dr. Janjigian on the JAVELIN Gastric 100 Study With Avelumab in Gastric/GEJ Cancer

April 14th 2020

Yelena Y. Janjigian, MD, discusses results from the phase III JAVELIN Gastric 100 study evaluating avelumab in gastric or gastroesophageal cancer.

Dr. O'Reilly on the Potential Role of Veliparib in Pancreatic Cancer

April 14th 2020

Eileen O'Reilly, MD, discusses the potential role of veliparib in pancreatic cancer.

Dr. Ilson on the Utility of Zolbetuximab in Claudin-Positive Gastric Cancers

April 14th 2020

David H. Ilson, MD, PhD, discusses the utility of zolbetuximab in claudin-positive gastric cancers.

Dr. Abdul-Hay on the Future of Targeted Therapy in ALL

April 14th 2020

Mohammad Maher Abdul-Hay, MD, discusses the future of targeted therapy in acute lymphoblastic leukemia.

Dr. Davies on the Use of Carfilzomib in Multiple Myeloma

April 14th 2020

Faith E. Davies, MD, discusses the dosing of carfilzomib in the treatment of patients with multiple myeloma.

Dr. Pemmaraju on the Need for Collaboration in Myelofibrosis

April 14th 2020

Naveen Pemmaraju, MD, discusses the need for collaboration when diagnosing and treating patients with myelofibrosis.

Dr. Jain on GVHD From Allogeneic Stem Cell Transplant

April 14th 2020

Tania Jain, MBBS, discusses the potential for graft-versus-host disease as a complication of allogeneic stem cell transplant.

Dr. Morgan on the Role of Venetoclax in Multiple Myeloma

April 14th 2020

Gareth J. Morgan, MD, PhD, discusses the role of venetoclax in treating patients with multiple myeloma.

Dr. Salem on the Role of Locoregional Therapy in HCC

April 14th 2020

Riad Salem, MD, discusses the role of locoregional therapy in hepatocellular carcinoma.

Dr. Katz on Neoadjuvant Chemotherapy in Pancreatic Cancer

April 14th 2020

Matthew H.G. Katz, MD, FACS, discusses the benefit of neoadjuvant chemotherapy in patients with pancreatic cancer.

Dr. Hwang on the Utility of Antiandrogens in Metastatic Prostate Cancer

April 14th 2020

Clara Hwang, MD, discusses the utility of antiandrogens in patients with metastatic prostate cancer.

Dr. Schmaier on the Secondary Management of Thrombosis in Hematologic Malignancies

April 14th 2020

Alvin H. Schmaier, MD, discusses the secondary management of thrombosis in patients with hematologic malignancies.

Dr. Reckamp on Navigating Challenges Posed by COVID-19

April 14th 2020

Karen L. Reckamp, MD, MS, provides insight on how she is navigating challenges posed by the COVID-19 crisis.

Dr. Davies on Promise of Venetoclax in Relapsed/Refractory Myeloma

April 13th 2020

Faith E. Davies, MD, discusses the use of venetoclax as a precision medicine approach in patients with relapsed/refractory multiple myeloma.

Dr. Graff on Genomic Risk Prediction in HR+/HER2- Breast Cancer

April 11th 2020

Stephanie L. Graff, MD, discusses genomic risk prediction in patients with hormone receptor–positive, HER2-negative breast cancer.

Dr. Abou-Alfa on Sequencing Challenges in Metastatic HCC

April 11th 2020

Ghassan K. Abou-Alfa, MD, discusses sequencing challenges in metastatic hepatocellular carcinoma.

Dr. Patel on Data From the MEDALIST Trial in Low-Risk MDS

April 11th 2020

Prapti Patel, MD, discusses data from the MEDALIST trial on the use of luspatercept-aamt in patients with low-risk myelodysplastic syndromes.

Dr. Hamid on Promising Triplet Combinations Under Exploration in Melanoma

April 11th 2020

Omid Hamid, MD, discusses promising triplet combination under exploration in melanoma.